Share Price and Basic Stock Data
Last Updated: December 4, 2025, 2:04 am
| PEG Ratio | -95.16 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
A-1 Acid Ltd operates within the chemicals sector, specifically focusing on inorganic chemicals. The company’s stock price stood at ₹1,516, with a market capitalization of ₹1,744 Cr. Over the past few years, A-1 Acid Ltd reported fluctuating sales figures, peaking at ₹331 Cr. for the financial year ending March 2023. However, the latest full-year sales for FY 2024 dropped to ₹211 Cr., indicating a significant decline. In the trailing twelve months (TTM), the revenue recorded was ₹326 Cr. Quarterly sales have also shown volatility, with the highest quarterly sales recorded at ₹93.84 Cr. in June 2022, declining to ₹41.76 Cr. by December 2023, before rebounding to ₹61.04 Cr. in March 2024. This inconsistency in revenue reflects potential challenges in market demand and operational efficiency. The company’s ability to stabilize its revenue will be critical for maintaining investor confidence and achieving long-term growth.
Profitability and Efficiency Metrics
In terms of profitability, A-1 Acid Ltd reported a modest return on equity (ROE) of 7.82% and a return on capital employed (ROCE) of 10.6%. The operating profit margin (OPM) stood at 2.88%, which is relatively low compared to industry standards, indicating a tight margin environment. The company’s operating profit fluctuated significantly, with the highest recorded at ₹9 Cr. in FY 2022, dropping to ₹4 Cr. in FY 2023, and rising to ₹5 Cr. in FY 2024. The latest quarterly figures show operating losses in several quarters, including a negative operating profit margin of -0.52% in March 2023. The cash conversion cycle (CCC) was reported at 57 days, which is within typical sector ranges, but it highlights the company’s efficiency in managing its receivables, inventory, and payables. The interest coverage ratio (ICR) was strong at 8.50x, indicating that the company can comfortably meet its interest obligations, although the low profitability raises concerns about sustainability.
Balance Sheet Strength and Financial Ratios
A-1 Acid Ltd’s balance sheet exhibits a total borrowing of ₹22 Cr. against total reserves of ₹38 Cr., providing a debt-to-equity ratio of 0.22, which suggests a low leverage position. The company’s total assets were reported at ₹74 Cr., with fixed assets amounting to ₹11 Cr. This indicates a conservative financial structure, allowing for stability in times of economic uncertainty. The current ratio stood at 3.48, showcasing strong liquidity, which is favorable compared to the typical sector benchmarks. However, the price-to-book value (P/BV) ratio was reported at 8.29x, suggesting the stock may be overvalued relative to its book value. The enterprise value (EV) of ₹399.87 Cr. further emphasizes the market’s expectations of the company’s future performance. Overall, while the balance sheet shows a solid liquidity position, the high P/BV ratio may raise concerns among potential investors regarding the stock’s valuation.
Shareholding Pattern and Investor Confidence
The shareholding structure of A-1 Acid Ltd indicates a strong promoter holding of 70.03%, which reflects a high level of management commitment. Foreign institutional investors (FIIs) have increased their stake from 2.85% in March 2023 to 5.80% by June 2025, signaling growing confidence among institutional investors. Conversely, public shareholding has gradually declined from 30% in September 2022 to 24.17% in June 2025, suggesting a potential loss of interest among retail investors. The number of shareholders increased from 980 in September 2022 to 1,802 by June 2025, indicating a growing interest in the stock despite the falling public shareholding percentage. This mixed sentiment in investor confidence could affect the company’s stock performance moving forward. The stability of promoter holdings alongside increasing institutional interest may provide a buffer against volatility, but the declining public participation could pose risks to liquidity and market perception.
Outlook, Risks, and Final Insight
A-1 Acid Ltd faces significant challenges, including fluctuating revenue, low profitability margins, and a declining public shareholder base. The company needs to enhance its operational efficiency and stabilize its revenue streams to regain investor confidence. Risks include potential market volatility impacting sales, and the high P/BV ratio could deter new investors. Conversely, the robust promoter holding and improving institutional investments present strengths that could support the company’s future. Should the company successfully implement strategies to improve profitability and operational efficiency, it may stabilize and potentially enhance its market position. However, if market conditions worsen or operational challenges persist, the company could face further difficulties in maintaining its financial health and investor interest.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of A-1 Acid Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 3,119 Cr. | 48.1 | 125/40.8 | 155 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 14.6 Cr. | 29.2 | 48.0/25.8 | 63.6 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 204 Cr. | 261 | 410/238 | 12.2 | 211 | 3.07 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,260 Cr. | 506 | 728/408 | 30.6 | 157 | 0.59 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 328 Cr. | 420 | 536/376 | 16.0 | 144 | 0.71 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,715.50 Cr | 586.48 | 192.77 | 160.00 | 0.51% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93.84 | 86.11 | 79.03 | 71.62 | 58.97 | 47.20 | 41.76 | 61.04 | 70.71 | 77.76 | 74.33 | 109.62 | 64.69 |
| Expenses | 91.32 | 85.10 | 77.95 | 71.99 | 59.18 | 47.31 | 40.59 | 58.79 | 68.69 | 75.26 | 71.50 | 107.19 | 62.83 |
| Operating Profit | 2.52 | 1.01 | 1.08 | -0.37 | -0.21 | -0.11 | 1.17 | 2.25 | 2.02 | 2.50 | 2.83 | 2.43 | 1.86 |
| OPM % | 2.69% | 1.17% | 1.37% | -0.52% | -0.36% | -0.23% | 2.80% | 3.69% | 2.86% | 3.22% | 3.81% | 2.22% | 2.88% |
| Other Income | 2.18 | 0.41 | 0.80 | 2.96 | 1.61 | 1.15 | 0.39 | -0.19 | 0.24 | 0.07 | 0.11 | 0.05 | 0.09 |
| Interest | 0.47 | 0.35 | 0.54 | 0.47 | 0.22 | 0.15 | 0.13 | 0.26 | 0.26 | 0.34 | 0.68 | 0.38 | 0.42 |
| Depreciation | 1.05 | 0.96 | 1.03 | 0.96 | 0.89 | 0.90 | 0.90 | 0.90 | 0.88 | 0.89 | 0.90 | 0.92 | 0.69 |
| Profit before tax | 3.18 | 0.11 | 0.31 | 1.16 | 0.29 | -0.01 | 0.53 | 0.90 | 1.12 | 1.34 | 1.36 | 1.18 | 0.84 |
| Tax % | 26.42% | 90.91% | 41.94% | 6.90% | 37.93% | 300.00% | 60.38% | 17.78% | 25.00% | 27.61% | 26.47% | 27.97% | 28.57% |
| Net Profit | 2.34 | 0.02 | 0.19 | 1.07 | 0.18 | -0.04 | 0.21 | 0.75 | 0.84 | 0.97 | 1.00 | 0.84 | 0.60 |
| EPS in Rs | 2.03 | 0.02 | 0.17 | 0.93 | 0.16 | -0.03 | 0.18 | 0.65 | 0.73 | 0.84 | 0.87 | 0.73 | 0.52 |
Last Updated: August 20, 2025, 12:55 am
Below is a detailed analysis of the quarterly data for A-1 Acid Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 64.69 Cr.. The value appears to be declining and may need further review. It has decreased from 109.62 Cr. (Mar 2025) to 64.69 Cr., marking a decrease of 44.93 Cr..
- For Expenses, as of Jun 2025, the value is 62.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 107.19 Cr. (Mar 2025) to 62.83 Cr., marking a decrease of 44.36 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.86 Cr.. The value appears to be declining and may need further review. It has decreased from 2.43 Cr. (Mar 2025) to 1.86 Cr., marking a decrease of 0.57 Cr..
- For OPM %, as of Jun 2025, the value is 2.88%. The value appears strong and on an upward trend. It has increased from 2.22% (Mar 2025) to 2.88%, marking an increase of 0.66%.
- For Other Income, as of Jun 2025, the value is 0.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Mar 2025) to 0.09 Cr., marking an increase of 0.04 Cr..
- For Interest, as of Jun 2025, the value is 0.42 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.38 Cr. (Mar 2025) to 0.42 Cr., marking an increase of 0.04 Cr..
- For Depreciation, as of Jun 2025, the value is 0.69 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.92 Cr. (Mar 2025) to 0.69 Cr., marking a decrease of 0.23 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.84 Cr.. The value appears to be declining and may need further review. It has decreased from 1.18 Cr. (Mar 2025) to 0.84 Cr., marking a decrease of 0.34 Cr..
- For Tax %, as of Jun 2025, the value is 28.57%. The value appears to be increasing, which may not be favorable. It has increased from 27.97% (Mar 2025) to 28.57%, marking an increase of 0.60%.
- For Net Profit, as of Jun 2025, the value is 0.60 Cr.. The value appears to be declining and may need further review. It has decreased from 0.84 Cr. (Mar 2025) to 0.60 Cr., marking a decrease of 0.24 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.52. The value appears to be declining and may need further review. It has decreased from 0.73 (Mar 2025) to 0.52, marking a decrease of 0.21.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:06 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97 | 85 | 106 | 100 | 141 | 116 | 145 | 310 | 331 | 211 | 331 | 326 |
| Expenses | 93 | 82 | 99 | 104 | 143 | 112 | 141 | 301 | 326 | 206 | 321 | 317 |
| Operating Profit | 3 | 3 | 7 | -4 | -2 | 4 | 4 | 9 | 4 | 5 | 10 | 10 |
| OPM % | 4% | 4% | 6% | -4% | -2% | 3% | 3% | 3% | 1% | 2% | 3% | 3% |
| Other Income | 0 | 0 | 0 | 11 | 9 | 4 | 4 | 4 | 6 | 2 | 0 | 0 |
| Interest | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 2 | 1 | 1 | 2 | 0 | 3 | 3 | 3 | 4 | 4 | 4 | 3 |
| Profit before tax | 0 | 1 | 4 | 4 | 6 | 4 | 4 | 8 | 5 | 2 | 5 | 5 |
| Tax % | 25% | 26% | 33% | 49% | 25% | 24% | 34% | 26% | 24% | 36% | 27% | |
| Net Profit | 0 | 1 | 3 | 2 | 4 | 3 | 3 | 6 | 4 | 1 | 4 | 3 |
| EPS in Rs | 1.08 | 7.67 | 25.00 | 2.37 | 3.63 | 2.77 | 2.37 | 5.49 | 3.14 | 0.96 | 3.17 | 2.96 |
| Dividend Payout % | 0% | 16% | 0% | 0% | 0% | 0% | 0% | 27% | 48% | 157% | 47% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | -33.33% | 100.00% | -25.00% | 0.00% | 100.00% | -33.33% | -75.00% | 300.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -233.33% | 133.33% | -125.00% | 25.00% | 100.00% | -133.33% | -41.67% | 375.00% |
A-1 Acid Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 23% |
| 3 Years: | 2% |
| TTM: | 48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 4% |
| 3 Years: | -16% |
| TTM: | 94% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 79% |
| 3 Years: | 42% |
| 1 Year: | 173% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 8% |
| 3 Years: | 6% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 2:01 pm
Balance Sheet
Last Updated: December 4, 2025, 2:15 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 7 | 10 | 10 | 10 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 7 | 7 | 10 | 7 | 25 | 27 | 30 | 35 | 37 | 36 | 38 | 37 |
| Borrowings | 13 | 12 | 19 | 16 | 15 | 6 | 17 | 26 | 14 | 11 | 22 | 17 |
| Other Liabilities | 3 | 6 | 8 | 8 | 4 | 4 | 4 | 7 | 5 | 3 | 2 | 3 |
| Total Liabilities | 24 | 26 | 38 | 39 | 53 | 48 | 61 | 80 | 68 | 61 | 74 | 68 |
| Fixed Assets | 4 | 3 | 11 | 9 | 14 | 11 | 14 | 17 | 16 | 13 | 11 | 10 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 5 | 5 | 5 |
| Other Assets | 20 | 23 | 26 | 30 | 38 | 37 | 47 | 60 | 48 | 43 | 58 | 52 |
| Total Assets | 24 | 26 | 38 | 39 | 53 | 48 | 61 | 80 | 68 | 61 | 74 | 68 |
Below is a detailed analysis of the balance sheet data for A-1 Acid Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Reserves, as of Sep 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 38.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 1.00 Cr..
- For Borrowings, as of Sep 2025, the value is 17.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 22.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 68.00 Cr.. The value appears to be improving (decreasing). It has decreased from 74.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Other Assets, as of Sep 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Mar 2025) to 52.00 Cr., marking a decrease of 6.00 Cr..
- For Total Assets, as of Sep 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 6.00 Cr..
Notably, the Reserves (37.00 Cr.) exceed the Borrowings (17.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.00 | -9.00 | -12.00 | -20.00 | -17.00 | -2.00 | -13.00 | -17.00 | -10.00 | -6.00 | -12.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 69 | 87 | 76 | 89 | 70 | 78 | 91 | 54 | 42 | 53 | 56 |
| Inventory Days | 3 | 7 | 2 | 4 | 2 | 4 | 6 | 3 | 2 | 4 | 3 |
| Days Payable | 3 | 8 | 5 | 14 | 4 | 1 | 4 | 4 | 1 | 3 | 2 |
| Cash Conversion Cycle | 70 | 86 | 73 | 80 | 68 | 81 | 93 | 54 | 43 | 54 | 57 |
| Working Capital Days | 16 | 22 | 17 | 32 | 64 | 83 | 69 | 33 | 31 | 41 | 35 |
| ROCE % | 13% | 23% | 18% | 17% | 11% | 9% | 15% | 10% | 4% | 11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.95 | 3.14 | 5.48 | 2.37 |
| Diluted EPS (Rs.) | 0.95 | 3.14 | 5.48 | 2.37 |
| Cash EPS (Rs.) | 4.41 | 6.67 | 8.52 | 5.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.54 | 42.09 | 40.45 | 40.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.54 | 42.09 | 40.45 | 40.21 |
| Revenue From Operations / Share (Rs.) | 179.25 | 287.48 | 269.88 | 145.18 |
| PBDIT / Share (Rs.) | 5.60 | 9.27 | 11.46 | 7.68 |
| PBIT / Share (Rs.) | 2.48 | 5.79 | 8.55 | 4.88 |
| PBT / Share (Rs.) | 1.82 | 4.19 | 7.50 | 4.15 |
| Net Profit / Share (Rs.) | 1.28 | 3.19 | 5.61 | 2.73 |
| NP After MI And SOA / Share (Rs.) | 0.95 | 3.14 | 5.48 | 2.73 |
| PBDIT Margin (%) | 3.12 | 3.22 | 4.24 | 5.29 |
| PBIT Margin (%) | 1.38 | 2.01 | 3.16 | 3.35 |
| PBT Margin (%) | 1.01 | 1.45 | 2.78 | 2.86 |
| Net Profit Margin (%) | 0.71 | 1.11 | 2.07 | 1.88 |
| NP After MI And SOA Margin (%) | 0.53 | 1.09 | 2.03 | 1.88 |
| Return on Networth / Equity (%) | 2.29 | 7.46 | 13.55 | 6.79 |
| Return on Capital Employeed (%) | 5.57 | 12.45 | 18.76 | 10.97 |
| Return On Assets (%) | 1.72 | 5.33 | 7.91 | 4.47 |
| Long Term Debt / Equity (X) | 0.05 | 0.09 | 0.11 | 0.09 |
| Total Debt / Equity (X) | 0.22 | 0.29 | 0.55 | 0.41 |
| Asset Turnover Ratio (%) | 3.14 | 4.48 | 4.41 | 0.00 |
| Current Ratio (X) | 3.48 | 3.20 | 2.03 | 2.67 |
| Quick Ratio (X) | 3.33 | 3.11 | 1.94 | 2.56 |
| Interest Coverage Ratio (X) | 8.50 | 5.81 | 10.93 | 10.66 |
| Interest Coverage Ratio (Post Tax) (X) | 2.94 | 3.00 | 6.35 | 4.79 |
| Enterprise Value (Cr.) | 399.87 | 401.40 | 325.92 | 115.99 |
| EV / Net Operating Revenue (X) | 1.94 | 1.21 | 1.05 | 0.79 |
| EV / EBITDA (X) | 62.10 | 37.67 | 24.72 | 15.10 |
| MarketCap / Net Operating Revenue (X) | 1.92 | 1.18 | 0.96 | 0.68 |
| Price / BV (X) | 8.29 | 8.07 | 6.45 | 2.48 |
| Price / Net Operating Revenue (X) | 1.92 | 1.18 | 0.96 | 0.68 |
| EarningsYield | 0.00 | 0.01 | 0.02 | 0.02 |
After reviewing the key financial ratios for A-1 Acid Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
- For Diluted EPS (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
- For Cash EPS (Rs.), as of Mar 24, the value is 4.41. This value is within the healthy range. It has decreased from 6.67 (Mar 23) to 4.41, marking a decrease of 2.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 41.54. It has decreased from 42.09 (Mar 23) to 41.54, marking a decrease of 0.55.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 41.54. It has decreased from 42.09 (Mar 23) to 41.54, marking a decrease of 0.55.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 179.25. It has decreased from 287.48 (Mar 23) to 179.25, marking a decrease of 108.23.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 5.60. This value is within the healthy range. It has decreased from 9.27 (Mar 23) to 5.60, marking a decrease of 3.67.
- For PBIT / Share (Rs.), as of Mar 24, the value is 2.48. This value is within the healthy range. It has decreased from 5.79 (Mar 23) to 2.48, marking a decrease of 3.31.
- For PBT / Share (Rs.), as of Mar 24, the value is 1.82. This value is within the healthy range. It has decreased from 4.19 (Mar 23) to 1.82, marking a decrease of 2.37.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 1.28. This value is below the healthy minimum of 2. It has decreased from 3.19 (Mar 23) to 1.28, marking a decrease of 1.91.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 2. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
- For PBDIT Margin (%), as of Mar 24, the value is 3.12. This value is below the healthy minimum of 10. It has decreased from 3.22 (Mar 23) to 3.12, marking a decrease of 0.10.
- For PBIT Margin (%), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 10. It has decreased from 2.01 (Mar 23) to 1.38, marking a decrease of 0.63.
- For PBT Margin (%), as of Mar 24, the value is 1.01. This value is below the healthy minimum of 10. It has decreased from 1.45 (Mar 23) to 1.01, marking a decrease of 0.44.
- For Net Profit Margin (%), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 1.11 (Mar 23) to 0.71, marking a decrease of 0.40.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 8. It has decreased from 1.09 (Mar 23) to 0.53, marking a decrease of 0.56.
- For Return on Networth / Equity (%), as of Mar 24, the value is 2.29. This value is below the healthy minimum of 15. It has decreased from 7.46 (Mar 23) to 2.29, marking a decrease of 5.17.
- For Return on Capital Employeed (%), as of Mar 24, the value is 5.57. This value is below the healthy minimum of 10. It has decreased from 12.45 (Mar 23) to 5.57, marking a decrease of 6.88.
- For Return On Assets (%), as of Mar 24, the value is 1.72. This value is below the healthy minimum of 5. It has decreased from 5.33 (Mar 23) to 1.72, marking a decrease of 3.61.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.05, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has decreased from 0.29 (Mar 23) to 0.22, marking a decrease of 0.07.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 3.14. It has decreased from 4.48 (Mar 23) to 3.14, marking a decrease of 1.34.
- For Current Ratio (X), as of Mar 24, the value is 3.48. This value exceeds the healthy maximum of 3. It has increased from 3.20 (Mar 23) to 3.48, marking an increase of 0.28.
- For Quick Ratio (X), as of Mar 24, the value is 3.33. This value exceeds the healthy maximum of 2. It has increased from 3.11 (Mar 23) to 3.33, marking an increase of 0.22.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 8.50. This value is within the healthy range. It has increased from 5.81 (Mar 23) to 8.50, marking an increase of 2.69.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.94. This value is below the healthy minimum of 3. It has decreased from 3.00 (Mar 23) to 2.94, marking a decrease of 0.06.
- For Enterprise Value (Cr.), as of Mar 24, the value is 399.87. It has decreased from 401.40 (Mar 23) to 399.87, marking a decrease of 1.53.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.94. This value is within the healthy range. It has increased from 1.21 (Mar 23) to 1.94, marking an increase of 0.73.
- For EV / EBITDA (X), as of Mar 24, the value is 62.10. This value exceeds the healthy maximum of 15. It has increased from 37.67 (Mar 23) to 62.10, marking an increase of 24.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 1.92, marking an increase of 0.74.
- For Price / BV (X), as of Mar 24, the value is 8.29. This value exceeds the healthy maximum of 3. It has increased from 8.07 (Mar 23) to 8.29, marking an increase of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 1.92, marking an increase of 0.74.
- For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in A-1 Acid Ltd:
- Net Profit Margin: 0.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.57% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.29% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.94
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 1 (Industry average Stock P/E: 192.77)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Corporate House No. A-1, Shivalik Business Centre, Ahmedabad Gujarat 380059 | info@a1acid.com http://www.a1acid.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harshadkumar Naranbhai Patel | Chairman & Managing Director |
| Mr. Jitendra Naranbhai Patel | Whole Time Director |
| Mr. Utkarsh Harshadkumar Patel | Whole Time Director |
| Mrs. Lajju Hemang Shah | Independent Director |
| Mr. Chirag Rajnikant Shah | Independent Director |
| Mrs. Krishna Utkarsh Patel | Non Executive Director |
| Mr. Nitin Rikhavbhai Shah | Independent Director |
| Mr. Suresh Somnath Dave | Independent Director |
| Mr. Shailesh Natverlal Thakkar | Independent Director |
A-1 Acid Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹353.80 |
| Previous Day | ₹348.80 |
FAQ
What is the intrinsic value of A-1 Acid Ltd?
A-1 Acid Ltd's intrinsic value (as of 04 December 2025) is 2928.55 which is 21.27% higher the current market price of 2,415.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 2,777 Cr. market cap, FY2025-2026 high/low of 2,817/372, reserves of ₹37 Cr, and liabilities of 68 Cr.
What is the Market Cap of A-1 Acid Ltd?
The Market Cap of A-1 Acid Ltd is 2,777 Cr..
What is the current Stock Price of A-1 Acid Ltd as on 04 December 2025?
The current stock price of A-1 Acid Ltd as on 04 December 2025 is 2,415.
What is the High / Low of A-1 Acid Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of A-1 Acid Ltd stocks is 2,817/372.
What is the Stock P/E of A-1 Acid Ltd?
The Stock P/E of A-1 Acid Ltd is 1,106.
What is the Book Value of A-1 Acid Ltd?
The Book Value of A-1 Acid Ltd is 42.3.
What is the Dividend Yield of A-1 Acid Ltd?
The Dividend Yield of A-1 Acid Ltd is 0.06 %.
What is the ROCE of A-1 Acid Ltd?
The ROCE of A-1 Acid Ltd is 10.6 %.
What is the ROE of A-1 Acid Ltd?
The ROE of A-1 Acid Ltd is 7.82 %.
What is the Face Value of A-1 Acid Ltd?
The Face Value of A-1 Acid Ltd is 10.0.